Prioritization of research addressing antipsychotics for adolescents and young adults with bipolar disorder
- PMID: 24567115
- DOI: 10.7326/M13-2549
Prioritization of research addressing antipsychotics for adolescents and young adults with bipolar disorder
Abstract
Despite a paucity of high-quality evidence about benefits and harms, antipsychotic medication use among adolescents and young adults with bipolar disorder is increasing. The Patient-Centered Outcomes Research Institute tasked the Duke Evidence Synthesis Group with creating a prioritized agenda for research in this area that would incorporate the perspectives of relevant stakeholders. We identified a list of potential evidence gaps by reviewing existing literature and engaged a diverse group of 9 stakeholders to expand and refine this list. Using a forced-ranking prioritization method, stakeholders prioritized 10 of 23 potential evidence gaps as the most pressing for future research. These evidence gaps relate to 3 areas: the comparative effectiveness of intervention strategies, the effect of antipsychotics on patient-centered outcomes, and the influence of various patient characteristics on antipsychotic effectiveness. In addition to presenting these findings, we suggest appropriate study designs for addressing the stakeholder-prioritized research questions.
Similar articles
-
Prioritization of research addressing management strategies for ductal carcinoma in situ.Ann Intern Med. 2014 Apr 1;160(7):484-91. doi: 10.7326/M13-2548. Ann Intern Med. 2014. PMID: 24567146
-
Use of antipsychotic medications in pediatric and young adult populations: future research needs.J Psychiatr Pract. 2015 Jan;21(1):26-36. doi: 10.1097/01.pra.0000460619.10429.4c. J Psychiatr Pract. 2015. PMID: 25603449
-
Prioritization of patient-centered comparative effectiveness research for osteoarthritis.Ann Intern Med. 2014 Jun 17;160(12):836-41. doi: 10.7326/M14-0318. Ann Intern Med. 2014. PMID: 24821227
-
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: Future research needs prioritization.Am Heart J. 2012 May;163(5):777-782.e8. doi: 10.1016/j.ahj.2012.02.016. Am Heart J. 2012. PMID: 22607854 Review.
-
Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.Minerva Pediatr. 2008 Feb;60(1):87-101. Minerva Pediatr. 2008. PMID: 18277368 Review.
Cited by
-
Global, regional and national burdens of bipolar disorders in adolescents and young adults: a trend analysis from 1990 to 2019.Gen Psychiatr. 2024 Feb 21;37(1):e101255. doi: 10.1136/gpsych-2023-101255. eCollection 2024. Gen Psychiatr. 2024. PMID: 38390238 Free PMC article.
-
Future research prioritization in cardiac resynchronization therapy.Am Heart J. 2020 May;223:48-58. doi: 10.1016/j.ahj.2020.02.011. Epub 2020 Feb 21. Am Heart J. 2020. PMID: 32163753 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical